Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 4, 2012, Pages 278-284

  Notarnicola, Angela ^a   Moretti, Lorenzo ^a   Martucci, Antonio ^a   Spinarelli, Antonio ^a   Tafuri, Silvio ^a   Pesce, Vito ^a   Moretti, Biagio ^a  

^a POLICLINICO   (Italy)

Author keywords

bleeding; dosage; fibrin sealant; knee arthroplasty

Indexed keywords

FIBRIN GLUE; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; FIBRIN TISSUE ADHESIVE; HEMOGLOBINS; HUMANS; KNEE; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 84861100724     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283518846     Document Type: Article

References (53)

1. Jackson MR, MacPhee MJ, Drohan WN, Alving BM. Fibrin sealant: current and potential clinical applications. Blood Coagul Fibrinolysis 1996;7:737-746.
2. Sirieix D, Chemla E, Castier Y, Massonnet-Castel S, Fabiani JN, Baron JF. Comparative study of different biological glues in an experimental model of surgical bleeding in anesthetized rats: platelet-rich and -poor plasma-based glue with and without aprotinin versus commercial fibrinogen-based glue. Ann Vasc Surg 1998;12:311-316.
3. Park W, Kim WH, Lee CH, Kim DY, Choi JH, Huh JW, et al. Comparison of two fibrin glues in anastomoses and skin closure. J Vet Med A Physiol Pathol Clin Med 2002;49:385-389.
4. Wang GJ, Goldthwaite CA Jr, Burks SG, Spotnitz WD, Orthopaedic Research Group. Experience improves successful use of fibrin sealant in total knee arthroplasty: implications for surgical education. J Long Term Eff Med Implants 2003;13:389-397.
5. Kawamura M, Gika M, Izumi Y, Horinouchi H, Shinya N, Mukai M, Kobayashi K. The sealing effect of fibrin glue against alveolar air leakage evaluated up to 48h: comparison between different methods of application. Eur J Cardiothorac Surg 2005;28:39-42.
6. Steuten L, Vallejo-Torres L, Bastide P, Buxton M. Analysing uncertainty around costs of innovative medical technologies: the case of fibrin sealant (QUIXIL) for total knee replacement. Health Policy 2009;89:46-57.
7. ™]): a review of its use as supportive treatment for haemostasis in surgery. Drugs 2011;71:1893-1915.
8. Mylod AG Jr, France MP, Muser DE, Parsons JR. Perioperative blood loss associated with total knee arthroplasty: a comparison of procedures performed with and without cementing. J Bone Joint Surg Am 1990;72:1010-1012.
9. Lemos MJ, Healy WL. Blood transfusion in orthopaedic operations. J Bone Joint Surg Am 1996;78:1260-1270.
10. Knight JL, Sherer D, Guo J. Blood transfusion strategies for total knee arthroplasty: minimizing autologous blood wastage, risk of homologous blood transfusion, and transfusion cost. J Arthroplasty 1998;13:70-76.
11. Spence RK. Anemia in the patient undergoing surgery and the transfusion decision: a review. Clin Orthop Relat Res 1998;357:19-29.
12. Miller RD, von Ehrenburg W. Controversies in transfusion medicine: Indications for autologous and allogenic transfusion should be the same: con. Transfusion 1995;35:450-452.
13. Linden JV. Errors in transfusion medicine: scope of the problem. Arch Pathol Lab Med 1999;123:563-565.
14. Everts PA, Devilee RJ, Brown Mahoney C, Eeftinck-Schattenkerk M, Box HA, Knape JT, van Zundert A. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand 2006;50:593-599.
15. Burkart BC, Bourne RB, Rorabeck CH, Kirk PG, Nott L. The efficacy of tourniquet release in blood conservation after total knee arthroplasty. Clin Orthop Relat Res 1994;299:147-152.
16. Shaieb MD, Watson BN, Atkinson RE. Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis. J Arthroplasty 1999;14:432-438.
17. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999;81:2-10.
18. Gollwitzer H, Burgkart R, Diehl P, Gradinger R, Buhren V. Therapy of arthrofibrosis after total knee arthroplasty. Orthopade 2006;35:143-215.
19. Everts PA, Devilee RJ, Oosterbos CJ, Mahoney CB, Schattenkerk ME, Knape JT, van Zundert A. Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc 2007;15:888-894.
20. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 1999;81:1580-1588.
21. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 2001;83-A:1503-1505.
22. Denis M, Moffet H, Caron F, Ouellet D, Paquet J, Nolet L. Effectiveness of continuous passive motion and conventional physical therapy after total knee arthroplasty: a randomized clinical trial. Phys Ther 2006;86:174-185.
23. Crawford DA, Scully W, McFadden L, Manoso M. Mil Preoperative predictors of length of hospital stay and discharge disposition following primary total knee arthroplasty at a military medical center. Mil Med 2011;176:304-307.
24. Oldmeadow LB, McBurney H, Robertson VJ. Hospital stay and discharge outcomes after knee arthroplasty: implications for physiotherapy practice. Aust J Physiother 2002;48:117-121.
25. Barbieri A, Vanhaecht K, Van Herck P, Sermeus W, Faggiano F, Marchisio S, Panella M. Effects of clinical pathways in the joint replacement: a metaanalysis. BMC Med 2009;7:32.
26. Nelson CL. A guide to reduce allogeneic transfusions in elective orthopaedic surgery. Instr Course Lect 2005;54:35-41.
27. Sculco TP. Blood management in orthopedic surgery. Am J Surg 1995;170:60S-63S.
28. Churchill WH, McGurk S, Chapman RH, Wallace EL, Bertholf MF, Goodnough LT, et al. The Collaborative Hospital Transfusion Study: variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery. Transfusion 1998;38:530-539.
29. Scott BH, Seifert FC, Glass PS, Grimson R. Blood use in patients undergoing coronary artery bypass surgery: impact of cardiopulmonary bypass pump, hematocrit, gender, age, and body weight. Anesth Analg 2003;97:958-963.
30. Nuttall GA, Santrach PJ, Oliver WC Jr, Horlocker TT, Shaughnessy WJ, Cabanela ME, Bryant S. The predictors of red cell transfusions in total hip arthroplasties. Transfusion 1996;36:144-149.
31. Thompson CA, Kyle R, Gertz M, Heit J, Pruthi R, Pardanani A. Systemic AL amyloidosis with acquired factor X deficiency: a study of perioperative bleeding risk and treatment outcomes in 60 patients. Am J Hematol 2010;85:171-173.
32. Christodoulou AG, Ploumis AL, Terzidis IP, Chantzidis P, Metsovitis SR, Nikiforos DG. The role of timing of tourniquet release and cementing on perioperative blood loss in total knee replacement. Knee 2004;11:313-317.
33. Jorn LP, Lindstrand A, Toksvig-Larsen S. Tourniquet release for hemostasis increases bleeding. A randomized study of 77 knee replacements. Acta Orthop Scand 1999;70:265-267.
34. Vandenbussche E, Duranthon LD, Couturier M, Pidhorz L, Augereau B. The effect of tourniquet use in total knee arthroplasty. Int Orthop 2002;26:306-309.
35. Pagnano M, Cushner FD, Hansen A, et al. Blood management in two-stage revision knee arthroplasty for deep prosthetic infection. Clin Orthop Relat Res 1999;367:238-242.
36. Rama KRBS, Apsingi S, Poovali S, et al. Timing of tourniquet release in knee arthroplasty. Meta-analysis of randomized, controlled trials. J Bone Joint Surg Am 2007;89:699-705.
37. Santavirta S, Hockerstedt K, Linden H. Pneumatic tourniquet and limb blood flow. Acta Orthop Scand 1978;49:565-570.
38. Silver R, de la Garza J, Rang M, Koreska J. Limb swelling after release of a tourniquet. Clin Orthop Relat Res 1986;206:86-89.
39. Aglietti P, Baldini A, Vena LM, Abbate R, Fedi S, Falciani M. Effect of tourniquet use on activation of coagulation in total knee replacement. Clin Orthop Relat Res 2000;371:169-177.
40. Klenerman L, Chakrabarti R, Mackie I, Brozovic M, Stirling Y. Changes in haemostatic system after application of a tourniquet. Lancet 1977;1:970-972.
41. Fahmy NR, Patel DG. Hemostatic changes and postoperative deep-vein thrombosis associated with use of a pneumatic tourniquet. J Bone Joint Surg Am 1981;63:461-465.
42. Barwell J, Anderson G, Hassan A, Rawlings I. The effects of early tourniquet release during total knee arthroplasty: a prospective randomized doubleblind study. J Bone Joint Surg Br 1997;79:265-268.
43. Hersekli MA, Akpinar S, Ozkoc G, Ozalay M, Uysal M, Cesur N, Tandogan RN. The timing of tourniquet release and its influence on blood loss after total knee arthroplasty. Int Orthop 2004;28:138-141.
44. Ishii Y, Matsuda Y. Effect of the timing of tourniquet release on perioperative blood loss associated with cementless total knee arthroplasty: a prospective randomized study. J Arthroplasty 2005;20:977-983.
45. Jorn LP, Lindstrand A, Toksvig-Larsen S. Tourniquet release for hemostasis increases bleeding. A randomized study of 77 knee replacements. Acta Orthop Scand 1999;70:265-267.
46. Lotke PA, Faralli VJ, Orenstein EM, Ecker ML. Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion. J Bone Joint Surg Am 1991;73:1037-1040.
47. Newman JH, Jackson JP, Waugh W. Timing of tourniquet removal after knee replacement. J R Soc Med 1979;72:492-494.
48. Schuh A, Hausel M, Salminen S. Effect of tourniquet use on blood loss in total knee arthroplasty. Zentralbl Chir 2003;128:866-870.
49. Widman J, Isacson J. Surgical hemostasis after tourniquet release does not reduce blood loss in knee replacement. A prospective randomized study of 81 patients. Acta Orthop Scand 1999;70:268-270.
50. Yagi T, Ohno K, Ohtera K, Otokozawa C. The efficacy of tourniquet release in blood conservation following cementless total knee arthroplasty. J AAOS 1995;19:332.
51. Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, et al. Low-molecular-weight heparin prophylaxis using dalteparin extended outofhospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a doubleblind, randomized comparison. Arch Intern Med 2000;160:2199-2220.
52. Francis CW, Pellegrini VD Jr, Totterman S, Boyd AD Jr, Marder VJ, Liebert KM, et al. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin. J Bone Joint Surg Am 1997;79:1365-1372.
53. Colwell CW Jr, Collis DK, Paulson R, McCutchen JW, Bigler GT, Lutz S, Hardwick ME. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 1999;81:932-934.